HIV-protease Inhibitors for the Treatment of Cancer: Repositioning HIV Protease Inhibitors While Developing More Potent NO-hybridized Derivatives?

International Journal of Cancer - United States
doi 10.1002/ijc.30529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

HIV Protease Inhibitors and Obesity

Current Opinion in Endocrinology, Diabetes and Obesity
Internal MedicineNutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2010English

Developing HIV-1 Protease Inhibitors Through Stereospecific Reactions in Protein Crystals

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2016English

Oral Candidiasis in HIV+ Patients Under Treatment With Protease Inhibitors

Brazilian Oral Research
2008English

HIV Protease Inhibitors and Mortality Following Kidney Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Molecular Recognition of Cyclic Urea HIV-1 Protease Inhibitors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

HIV-protease Inhibitors Block the Enzymatic Activity of Purified Ste24p

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2008English

Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease

2012English

Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages

Viruses
VirologyInfectious Diseases
2018English

Pharmacokinetic Interactions Between Cyclosporine and Protease Inhibitors in HIV + Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy